Literature DB >> 25797999

Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development.

Sylvie E Kandel1, Larry C Wienkers2, Jed N Lampe3.   

Abstract

The cytochrome P450 (CYP) enzymes are a versatile superfamily of heme-containing monooxygenases, perhaps best known for their role in the oxidation of xenobiotic compounds. However, due to their unique oxidative chemistry, CYPs are also important in natural product drug discovery and in the generation of active metabolites with unique therapeutic properties. New tools for the analysis and production of CYP metabolites, including microscale analytical technologies and combinatorial biosynthesis, are providing medicinal chemists with the opportunity to use CYPs as a novel platform for lead discovery and development. In this review, we will highlight some of the recent examples of drug leads identified from CYP metabolites and the exciting possibilities of using CYPs as catalysts for future drug discovery.

Entities:  

Keywords:  14-hydroxyclarithromycin; 4-hydroxyatorvastatin; 6-hydroxybuspirone; cytochrome P450; drug discovery; fexofenadine; metabolites; metabolizer phenotype; microscale microfluidics; natural products

Year:  2014        PMID: 25797999      PMCID: PMC4365796          DOI: 10.1016/B978-0-12-800167-7.00022-5

Source DB:  PubMed          Journal:  Annu Rep Med Chem        ISSN: 0065-7743            Impact factor:   1.059


  58 in total

Review 1.  Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation.

Authors:  Marc Morant; Søren Bak; Birger Lindberg Møller; Danièle Werck-Reichhart
Journal:  Curr Opin Biotechnol       Date:  2003-04       Impact factor: 9.740

2.  Pigments of rat liver microsomes.

Authors:  M KLINGENBERG
Journal:  Arch Biochem Biophys       Date:  1958-06       Impact factor: 4.013

Review 3.  Role of pharmacologically active metabolites in drug discovery and development.

Authors:  Aberra Fura
Journal:  Drug Discov Today       Date:  2006-02       Impact factor: 7.851

4.  The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates.

Authors:  G C MUELLER; J A MILLER
Journal:  J Biol Chem       Date:  1948-11       Impact factor: 5.157

5.  Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6.

Authors:  Zhongliu-Liu Wu; Pramod Aryal; Olivier Lozach; Laurent Meijer; F Peter Guengerich
Journal:  Chem Biodivers       Date:  2005-01       Impact factor: 2.408

6.  Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison.

Authors:  D A Fuchs; R K Johnson
Journal:  Cancer Treat Rep       Date:  1978-08

7.  Oxidation of indole by cytochrome P450 enzymes.

Authors:  E M Gillam; L M Notley; H Cai; J J De Voss; F P Guengerich
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

Review 8.  Hydrocarbon hydroxylation by cytochrome P450 enzymes.

Authors:  Paul R Ortiz de Montellano
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

9.  Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats.

Authors:  Y Kohno; H Yoshida; T Suwa; T Suga
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

10.  Use of terfenadine and contraindicated drugs.

Authors:  D Thompson; G Oster
Journal:  JAMA       Date:  1996-05-01       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.